Evidence map›Paper›PMID 39391726›Full record

ArticleiScience2024

PepCA: Unveiling protein-peptide interaction sites with a multi-input neural network model.

Junxiong Huang, Weikang Li, Bin Xiao, Chunqing Zhao, Hancheng Zheng, Yingrui Li, Jun Wang

Abstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Peptide-protein docking: from physics-based models to generative intelligence.Chemical communications (Cambridge, England) · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junxiong HuangiCarbonX (Zhuhai) Company Limited, Zhuhai, Guangdong, China.
Weikang LiiCarbonX (Zhuhai) Company Limited, Zhuhai, Guangdong, China.
Bin XiaoiCarbonX (Zhuhai) Company Limited, Zhuhai, Guangdong, China.
Chunqing ZhaoiCarbonX (Zhuhai) Company Limited, Zhuhai, Guangdong, China.
Hancheng ZhengiCarbonX (Zhuhai) Company Limited, Zhuhai, Guangdong, China.
Yingrui LiiCarbonX (Zhuhai) Company Limited, Zhuhai, Guangdong, China.
Jun WangiCarbonX (Zhuhai) Company Limited, Zhuhai, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protein-peptide interaction plays a pivotal role in fields such as drug development, yet remains underexplored experimentally and challenging to model computationally. Herein, we introduce PepCA, a sequence-based approach for predicting peptide-binding sites on proteins. A primary obstacle in predicting peptide-protein interactions is the difficulty in acquiring precise protein structures, coupled with the uncertainty of polypeptide configurations. To address this, we first encode protein sequences using the Evolutionary Scale Modeling 2 (ESM-2) pre-trained model to extract latent structural information. Additionally, we have developed a multi-input coattention mechanism to concurrently update the encoding of both peptide and protein residues. PepCA integrates this module within an encoder-decoder structure. This model's high precision in identifying binding sites significantly advances the field of computational biology, offering vital insights for peptide drug development and protein science.

Indexed as

BiomoleculesMachine learningMolecular interactionProtein foldingSoftware program for structure determination

Identifiers

PMID39391726
PMCPMC11465048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.